Methicillin-resistant Staphylococcus aureus (MRSA) has been reported to cause conjunctivitis,1 endophthalmitis, keratitis following refractive surgery, corneal ulcer, wound infection after clear-cornea cataract surgery, and dacryocystitis.2 We report a case of community-acquired MRSA conjunctivitis that progressed to periorbital soft tissue invasion and destruction.
A healthy 31-year-old man was referred for nonresolving conjunctivitis in the right eye. One week earlier, he developed redness and swelling of the right lower eyelid with conjunctival injection. After 4 days, he was evaluated in a local emergency department and began receiving cephalexin and gatifloxacin (Zymar) 4 times daily. The eyelid swelling partially resolved but the eye remained red, and the patient developed heavy yellow mucopurulent discharge that repeatedly accumulated in the medial canthus. He denied diplopia or epiphora. He was afebrile and felt well otherwise. He had no risk factors for immunosuppression or colonization with antibiotic-resistant bacteria.
Visual acuity without correction was 20/25 OU. Ocular motility was normal. The left eye and adnexa were normal. The right lower eyelid showed minimal edema and mild redness, which was worse nasally (Figure, A). There was +3 large vessel bulbar conjunctival injection that was greater nasally. The inferior palpebral conjunctiva was intensely inflamed and had 2 areas of ulceration down to the tarsus (Figure, B). A narrow tract of deep tissue necrosis with a blind end originated inferior to the caruncle; it probed inferonasally to a depth of approximately 7 mm. The anterior segment was otherwise normal. An orbital computed tomographic scan showed preseptal and postseptal edema with inflammatory changes in the nasal extraconal fat, without discrete abscess. Culture of the drainage grew MRSA susceptible to vancomycin hydrochloride, rifampin, and clindamycin phosphate but resistant to penicillin and cefazolin sodium. The patient was treated for 7 days with intravenous vancomycin and tobramycin sulfate as well as oral rifampin and then for 7 days with oral trimethoprim sulfa double strength with clinical resolution. Nasal cultures for MRSA were negative.
We report an unusual case of a healthy young patient who developed necrotizing community-acquired MRSA conjunctivitis that caused palpebral conjunctival ulceration and destruction of postseptal soft tissue with invasion of extraconal fat. Despite the depth of infection, external signs of eyelid inflammation were modest. There is 1 reported case of MRSA dacryocystitis with fistula formation,2 but fistulas can occur with any severe bacterial dacryocystitis. Our patient had a true invasive infection that arose from the ocular surface. He had no apparent risk factors for MRSA colonization. In the setting of diffuse palpebral conjunctival inflammation, the deeper tissue destruction might have been overlooked; an important historical clue was the repeated accumulation of pus over the caruncle but not elsewhere. Dacryocystitis was unlikely owing to the lack of epiphora.
Community-acquired MRSA can produce large abscesses or carbuncles, possibly through production of a specific skin necrotic cytotoxin.3 Culture with sensitivity is critical as these MRSA strains are resistant to all β-lactam antibiotics and may be resistant to clindamycin.4 The proportion of staphylococcal ocular surface infections showing methicillin resistance has increased from 4% in 1999 to 17% in 2006.5 Approximately 96% of MRSA ocular isolates are resistant to ciprofloxacin hydrochloride and 82% are resistant to levofloxacin.6 A typical empirical treatment for moderately severe conjunctivitis with preseptal inflammation is an oral cephalosporin combined with a topical fourth-generation quinolone; this is ineffective for MRSA.
Physicians should consider MRSA in patients with atypical conjunctivitis showing patchy necrosis of conjunctiva and should investigate any dimpled or eroded areas for evidence of deeper invasion. If invasion is found, the patient should be presumptively treated for MRSA with systemic vancomycin5 while awaiting the results of bacterial culture. An orbital MRSA abscess within fat is relatively sequestered from antibiotic penetration, may require surgical débridement, and could lead to extensive necrotic damage to orbital structures such as extraocular muscles and the lacrimal sac.
Correspondence: Dr Brown, Cabarrus Eye Center, 201 LePhillip Ct NE, Concord, NC 28025 (sbrownmd@cabarruseye.com).
Financial Disclosure: None reported.
1.Ross
JAbate
MA Topical vancomycin for the treatment of
Staphylococcus epidermidis and methicillin-resistant
Staphylococcus aureus conjunctivitis.
DICP 1990;24
(11)
1050, 1053
PubMedGoogle Scholar 2.Kubo
MSakuraba
TArai
YNakazawa
M Dacryocystorhinostomy for dacryocystitis caused by methicillin-resistant
Staphylococcus aureus: report of four cases.
Jpn J Ophthalmol 2002;46
(2)
177- 182
PubMedGoogle ScholarCrossref 3.Klevens
RMMorrison
MANadle
J
et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators, Invasive methicillin-resistant
Staphylococcus aureus infections in the United States.
JAMA 2007;298
(15)
1763- 1771
PubMedGoogle ScholarCrossref 4.Wallin
TRHern
HGFrazee
BW Community-associated methicillin-resistant
Staphylococcus aureus.
Emerg Med Clin North Am 2008;26
(2)
431- 455, ix
PubMedGoogle ScholarCrossref 5.Freidlin
JAcharya
NLietman
TMCevallos
VWhitcher
JPMargolis
TP Spectrum of eye disease caused by methicillin-resistant
Staphylococcus aureus.
Am J Ophthalmol 2007;144
(2)
313- 315
PubMedGoogle ScholarCrossref 6.Marangon
FBMiller
DMuallem
MSRomano
ACAlfonso
EC Ciprofloxacin and levofloxacin resistance among methicillin-sensitive
Staphylococcus aureus isolates from keratitis and conjunctivitis.
Am J Ophthalmol 2004;137
(3)
453- 458
PubMedGoogle ScholarCrossref